Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. XYZResearch published a report for global Immunotherapy Drugs market in this environment.
In terms of revenue, this research report indicated that the global Immunotherapy Drugs market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. Correspondingly, the forecast analysis of Immunotherapy Drugs industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The F. Hoffmann-La Roche aims at producing XX Immunotherapy Drugs in 2020, with XX % production to take place in global market, GlaxoSmithKline accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Immunotherapy Drugs Market by XYZResearch Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Immunotherapy Drugs Market?
F. Hoffmann-La Roche
GlaxoSmithKline
AbbVie
Amgen
Merck
Bristol-Myers Squibb
Novartis International
Eli Lilly and Company
Johnson & Johnson
AstraZeneca
...
Major Type of Immunotherapy Drugs Covered in XYZResearch report:
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha
Application Segments Covered in XYZResearch Market
Cancer
Autoimmune Diseases
Infectious Diseases
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Immunotherapy Drugs Market Analysis 2020, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Adult Vaccines -Product Introduction and Major Manufacturers
1.1.2 Checkpoint Inhibitors -Product Introduction and Major Manufacturers
1.1.3 Interferons Alpha -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Immunotherapy Drugs Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2015-2026)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2015-2026)
2.3 Application Breakdown Estimates & Forecast, by Application (2015-2026)
3 Regional Market Analysis
3.1 China Immunotherapy Drugs Market
3.1.1 Top Companies leading Immunotherapy Drugs Development in China (2015-2020)
3.1.2 Sales Value of Major Company in China Market (2015-2020)
3.1.3 China Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2015-2026)
3.2 EU Immunotherapy Drugs Market
3.2.1 Top Companies leading Immunotherapy Drugs Development in EU (2015-2020)
3.2.2 Sales Value of Major Company in EU Market (2015-2020)
3.2.3 EU Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2015-2026)
3.3 USA Immunotherapy Drugs Market
3.3.1 Top Companies leading Immunotherapy Drugs Development in USA (2015-2020)
3.3.2 Sales Value of Major Company in USA Market (2015-2020)
3.3.3 USA Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2015-2026)
3.4 Japan Immunotherapy Drugs Market
3.4.1 Top Companies leading Immunotherapy Drugs Development in Japan (2015-2020)
3.4.2 Sales Value of Major Company in Japan Market (2015-2020)
3.4.3 Japan Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2015-2026)
3.5 India Immunotherapy Drugs Market
3.5.1 Top Companies leading Immunotherapy Drugs Development in India (2015-2020)
3.5.2 Sales Value of Major Company in India Market (2015-2020)
3.5.3 India Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2015-2026)
3.6 Southeast Asia Immunotherapy Drugs Market
3.6.1 Top Companies leading Immunotherapy Drugs Development in Southeast Asia (2015-2020)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2015-2020)
3.6.3 Southeast Asia Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2015-2026)
3.7 South America Immunotherapy Drugs Market
3.7.1 Top Companies leading Immunotherapy Drugs Development in South America (2015-2020)
3.7.2 Sales Value of Major Company in South America Market (2015-2020)
3.7.3 South America Immunotherapy Drugs Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2015-2026)
4 Value Chain (Impact of COVID-19)
4.1 Immunotherapy Drugs Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Immunotherapy Drugs Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2026)
5.1 Global Immunotherapy Drugs Sales and Growth Rate (2021-2026)
5.2 Global Immunotherapy Drugs Sales Value and Growth Rate (2021-2026)
6 Immunotherapy Drugs Competitive Analysis
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Company Profiles
6.1.2 F. Hoffmann-La Roche Product Introduction
6.1.3 F. Hoffmann-La Roche Immunotherapy Drugs Production, Revenue (2015-2020)
6.1.4 SWOT Analysis
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Profiles
6.2.2 GlaxoSmithKline Product Introduction
6.2.3 GlaxoSmithKline Immunotherapy Drugs Production, Revenue (2015-2020)
6.2.4 SWOT Analysis
6.3 AbbVie
6.3.1 AbbVie Company Profiles
6.3.2 AbbVie Product Introduction
6.3.3 AbbVie Immunotherapy Drugs Production, Revenue (2015-2020)
6.3.4 SWOT Analysis
6.4 Amgen
6.4.1 Amgen Company Profiles
6.4.2 Amgen Product Introduction
6.4.3 Amgen Immunotherapy Drugs Production, Revenue (2015-2020)
6.4.4 SWOT Analysis
6.5 Merck
6.5.1 Merck Company Profiles
6.5.2 Merck Product Introduction
6.5.3 Merck Immunotherapy Drugs Production, Revenue (2015-2020)
6.5.4 SWOT Analysis
6.6 Bristol-Myers Squibb
6.6.1 Bristol-Myers Squibb Company Profiles
6.6.2 Bristol-Myers Squibb Product Introduction
6.6.3 Bristol-Myers Squibb Immunotherapy Drugs Production, Revenue (2015-2020)
6.6.4 SWOT Analysis
6.7 Novartis International
6.7.1 Novartis International Company Profiles
6.7.2 Novartis International Product Introduction
6.7.3 Novartis International Immunotherapy Drugs Production, Revenue (2015-2020)
6.7.4 SWOT Analysis
6.8 Eli Lilly and Company
6.8.1 Eli Lilly and Company Company Profiles
6.8.2 Eli Lilly and Company Product Introduction
6.8.3 Eli Lilly and Company Immunotherapy Drugs Production, Revenue (2015-2020)
6.8.4 SWOT Analysis
6.9 Johnson & Johnson
6.9.1 Johnson & Johnson Company Profiles
6.9.2 Johnson & Johnson Product Introduction
6.9.3 Johnson & Johnson Immunotherapy Drugs Production, Revenue (2015-2020)
6.9.4 SWOT Analysis
6.10 AstraZeneca
6.10.1 AstraZeneca Company Profiles
6.10.2 AstraZeneca Product Introduction
6.10.3 AstraZeneca Immunotherapy Drugs Production, Revenue (2015-2020)
6.10.4 SWOT Analysis
7 Conclusion
Executive Summary
Azoth Analytics has released a research report titled "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition)" which provides a complete analysis of the Global IgG Mediated Autoimmune Diseases Biologic Drugs industry in terms of market segmentatio...
Executive Summary
Azoth Analytics has released a research report titled "Global Antibiotic Drugs Market (2024 Edition)" which provides a complete analysis of the global Antibiotic Drugs industry in terms of market segmentation By Drug Class (Cephalosporin, Penicillin, Macrolides, Fluoro...
Overview of the Global Sex Hormone Drugs Market:
The report discusses everything a marketer requires before investing in the global Sex Hormone Drugs Market during the forecast period 2023-2030. It provides detailed...
Executive Summary
Azoth Analytics has released a research report titled "Incretin Based Drugs Market (2023 Edition)" which provides a complete analysis of the global Incretin Based Drugs industry in terms of market segmentation By Drug Type (Glucagon-like Peptide-1 Receptor Agonists, Di...
Overview of the Global Microecological Drugs Market :
The report discusses everything a marketer requires before investing in the global Microecological Drugs Market during the forecast period 2023-2030. It provide...
Overview of the Global Biosynthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Biosynthesis Peptide Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Chemical Synthesis Peptide Drugs Market:
The report discusses everything a marketer requires before investing in the global Chemical Synthesis Peptide Drugs Market during the forecast period 2...
Description
The global veterinary dermatology drugs market exhibits positive growth prospects, forecast to expand at a CAGR of 5.4% between 2023 and 2029 to reach USD 8.08 billion in value. Veterinary dermatology focuses on treating skin diseases and disorders in animal patients, covering both...
Overview of the Global Drug Rehabilitation Drugs Market :
The report discusses everything a marketer requires before investing in the global Drug Rehabilitation Drugs Market during the forecast period 2023-2030. It...
Overview of the Global Rosuvastatin Drugs Market:
The report discusses everything a marketer requires before investing in the global Rosuvastatin Drugs Market during the forecast period 2023-2030. It provides detail...